Article in International journal of molecular sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literature
Who cites it
1 citing paper in PubMed.
Frontiers in pharmacology · 2026
Article
4 · The record
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
6 authors.
Yehui HuHebei Administration of Traditional Chinese Medicine Collaborative Innovation Key Research Laboratory of Chinese Medicinal Resource Industrialization, College of Traditional Chinese Medicine, Hebei University, Baoding 071000, China.
Xiangui MeiCollege of Agronomy, Shandong Agricultural University, Taian 271018, China.
Yingying CuiCollege of Agronomy, Shandong Agricultural University, Taian 271018, China.
Zhenying WangCollege of Agronomy, Shandong Agricultural University, Taian 271018, China.
Chuanzhi KangState Key Laboratory for Quality Ensurance and Sustainable Use of Dao-di Herbs, National Resource Center for Chinese Materia Medica, Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing 100700, China.ORCID 0000-0002-2758-4785
Shengci FanHebei Administration of Traditional Chinese Medicine Collaborative Innovation Key Research Laboratory of Chinese Medicinal Resource Industrialization, College of Traditional Chinese Medicine, Hebei University, Baoding 071000, China.
Funding
China Agricultural Research System of MOF and MARA CARS-21Hebei Province Chengde Science and Technology Plan Project 202304B054Key project at central government level: The ability establishment of sustainable use for valuable Chinese medicine resources 2060302
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Metabolomics Provides Insight into the Chemical Characteristics Underlying Bioactivity Differences Among Various Parts of · full record | OpenQuestion